Use the Back button in your browser to see the other results of your search or to select another record.
Five-year follow-up of the OptiTrain trial on concurrent resistance and high-intensity interval training during chemotherapy for patients with breast cancer |
Anandavadivelan P, Mijwel S, Wiklander M, Kjoe PLM, Luijendijk M, Bergh J, Rundqvist H, Wengstrom Y |
Scientific Reports 2024 Jul 3;14(15333):Epub |
clinical trial |
4/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|